Matthias Merkenschlager

Dr. Matthias Merkenschlager


Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2006 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
VAVéronique Azuara
Véronique Azuara
PPPascale Perry
Pascale Perry
SSStephan Sauer
Stephan Sauer
MSMikhail Spivakov
Mikhail Spivakov
HJHelle F. Jørgensen
Helle F. Jørgensen
AFAmanda G. Fisher
Amanda G. Fisher

21 March 2010 in Nature
Verified
Journal Article
Open access
PDF file
MRMarc H. G. P. Raaijmakers
Marc H. G. P. Raaijmakers
SMSiddhartha Mukherjee
Siddhartha Mukherjee
SGShangqin Guo
Shangqin Guo
SZSiyi Zhang
Siyi Zhang
TKTatsuya Kobayashi
Tatsuya Kobayashi
DSDavid. T. Scadden
David. T. Scadden
Mesenchymal cells contribute to the ‘stroma’ of most normal and malignant tissues, with specific mesenchymal cells participating in the regulatory niches of stem cells. By examining how mesenchymal osteolineage cells modulate haematopoiesis, here we show that deletion of Dicer1 specifically in mouse osteoprogenitors, but not in mature osteoblasts, disrupts the integrity of haematopoiesis. Myelodysplasia resulted and acute myelogenous leukaemia emerged that had acquired several genetic abnormalities while having intact Dicer1. Examining gene expression altered in osteoprogenitors as a result of Dicer1 deletion showed reduced expression of Sbds, the gene mutated in Schwachman–Bodian–Diamond syndrome—a human bone marrow failure and leukaemia pre-disposition condition. Deletion of Sbds in mouse osteoprogenitors induced bone marrow dysfunction with myelodysplasia. Therefore, perturbation of specific mesenchymal subsets of stromal cells can disorder differentiation, proliferation and apoptosis of heterologous cells, and disrupt tissue homeostasis. Furthermore, primary stromal dysfunction can result in secondary neoplastic disease, supporting the concept of niche-induced oncogenesis.

1 February 2008 in Cell
Verified
Journal Article
Closed access
VPVania Parelho
Vania Parelho
SHSuzana Hadjur
Suzana Hadjur
MSMikhail Spivakov
Mikhail Spivakov
MLMarion Leleu
Marion Leleu
SSStephan Sauer
Stephan Sauer
MMMatthias Merkenschlager
Matthias Merkenschlager

3 June 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SSStephan Sauer
Stephan Sauer
LBLudovica Bruno
Ludovica Bruno
AHArnulf Hertweck
Arnulf Hertweck
David K. FinlayDavid K. Finlay
David K. Finlay
MLMarion Leleu
Marion Leleu
MMMatthias Merkenschlager
Matthias Merkenschlager
Regulatory T (Treg) cells safeguard against autoimmunity and immune pathology. Because determinants of the Treg cell fate are not completely understood, we have delineated signaling events that control thede novoexpression of Foxp3 in naive peripheral CD4 T cells and in thymocytes. We report that premature termination of TCR signaling and inibition of phosphatidyl inositol 3-kinase (PI3K) p110α, p110δ, protein kinase B (Akt), or mammalian target of rapamycin (mTOR) conferred Foxp3 expression and Treg-like gene expression profiles. Conversely, continued TCR signaling and constitutive PI3K/Akt/mTOR activity antagonised Foxp3 induction. At the chromatin level, di- and trimethylation of lysine 4 of histone H3 (H3K4me2 and -3) near theFoxp3transcription start site (TSS) and within the 5′ untranslated region (UTR) preceded active Foxp3 expression and, like Foxp3 inducibility, was lost upon continued TCR stimulation. These data demonstrate that the PI3K/Akt/mTOR signaling network regulates Foxp3 expression.

1 December 1997 in Cell
Verified
Journal Article
Closed access
KBKaren E Brown
Karen E Brown
SGSimon S Guest
Simon S Guest
SSStephen T Smale
Stephen T Smale
KHKyungmin Hahm
Kyungmin Hahm
MMMatthias Merkenschlager
Matthias Merkenschlager
AFAmanda G Fisher
Amanda G Fisher

31 August 2016 in Annual Review of Genomics and Human Genetics
Verified
Journal Article
Closed access
MMMatthias Merkenschlager
Matthias Merkenschlager
ENElphège P. Nora
Elphège P. Nora
Genome function, replication, integrity, and propagation rely on the dynamic structural organization of chromosomes during the cell cycle. Genome folding in interphase provides regulatory segmentation for appropriate transcriptional control, facilitates ordered genome replication, and contributes to genome integrity by limiting illegitimate recombination. Here, we review recent high-resolution chromosome conformation capture and functional studies that have informed models of the spatial and regulatory compartmentalization of mammalian genomes, and discuss mechanistic models for how CTCF and cohesin control the functional architecture of mammalian chromosomes.